Fig. 5

Long-term monitoring and follow-up of CAR T cells in treated DLBCLÂ or B-ALL patients. Ten patients (DLBCL) receiving axi-cel and 7 (4 B-ALL and 3 DLBCL) receiving tisa-cel were monitored using 28BBz or 28z ddPCR (blue lines, left Y-axis) on gDNA extracted from circulating PB cells. CD19 CAR T cell numeration (red lines, right Y-axis), obtained by FC, is plotted (green lines, right Y-axis) on the same respective graph. AUC: area under the curve day 0 to 28, calculated with GraphPad software. (*) highlights patients in whom CD19+ cells reappear